相关实验视频

Updated: Jan 16, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

博马龙与胆固醇结合对抗多药耐药细菌的抗菌作用

Feng Wang¹, Hongjun Li¹, Xiaoqiang Bao¹

¹Department of Respiratory and Critical Care Medicine, Shin-an International Hospital, Jiaxing, Zhejiang, China.

Frontiers in medicine

|September 26, 2025

概括

博马龙增强了对抗耐药性COPD病原体的素的有效性. 这种组合治疗显示出协同作用,改善细菌膜损伤,减少胆固醇剂量以获得更好的治疗结果.

科学领域:

微生物学微生物学
药理学药理学是指药理学的学科.
传染性疾病传染性疾病

背景情况:

在COPD患者中,耐药性呼吸道病原体带来了重大的治疗挑战.
胆固醇是一种关键的最后手段抗生素,但耐药性和毒性限制了它的使用.
需要组合策略来提高素的疗效和安全性.

研究的目的:

为了研究将博马龙与胆固醇结合对抗耐药性COPD病原体的抗菌作用.
评估本兹布罗马龙-胆固醇组合的协同潜力和潜在机制.
在一个相关的感染模型中评估组合疗法的体内疗效.

主要方法:

最低抑制度 (MIC) 确定和检查板测试以评估协同作用.
分析生长曲线和时间杀伤曲线以评估杀菌活性.
作用机制研究涉及膜损伤,ROS产生和ATP抑制.
在体内有效性评估的Galleria mellonella幼虫感染模型.

主要成果:

博马龙显著降低了胆固醇的MIC,其分数抑制度指数 (FICI) 值<0.5,表明了协同作用.
这种组合显示出增强的细菌生长抑制和强大的杀菌活性.
协同作用的机制包括增加细菌膜损伤,ROS积累和抑制ATP产生.
在体内,博马龙-胆固醇组合在多药耐药细菌感染模型中显著改善了生存率.

结论:

博马龙协同增强了对抗药物耐药性COPD病原体的胆固醇蛋白的抗菌活性.
组合疗法提供了一个有前途的策略,以克服耐药性和减少胆固醇素剂量.
这种方法扩大了非抗生素药物在对抗耐药性感染方面的潜在应用.

关键词:

慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.细菌的耐药性细菌的耐药性博马龙 (Benzbromarone) 是一种博马龙.科里斯 (Colistin) 是一个古老的城市.组合疗法治疗组合治疗.

更多相关视频

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Antibiotic Selection

Antibiotic Selection

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...